Crystalline forms of an androgen receptor modulator
US12018008B2 · kind B2 · utility
0Cited by
3References
41Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 26, 2021 |
| Grant date | Jun 25, 2024 |
| Priority date | — |
| Expiry date | Oct 2, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are amorphous and crystalline forms of the androgen receptor modulator 4-[7-(6-cyano-5-trifluoromethylpyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oct-5-yl]-2-fluoro-N-methylbenzamide. Also described are pharmaceutical compositions suitable for administration to a mammal that include the androgen receptor modulator, and methods of using the androgen receptor modulator, alone and in combination with other compounds, for treating diseases or conditions that are associated with androgen receptor activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.